EMCDDA Home
  • EN
Search

Figure INF-6. HCV antibody prevalence among injecting drug users: studies with national and sub-national coverage

Part (ii) Young injecting drug users (under age 25), 2010–11

 
 
CountryyearNationalSub-national
Related links:
Slovenia201110.5
Czech Republic201010.7
Malta201118.8
Hungary201119.522.610.33235.9
Austria201114.832.967.942.640.6
Belgium201125.025.0
Sweden201027.8
United Kingdom2010/201122.234.1
Slovakia201130.0
Germany201126.733.3
Portugal2010/201161.16.1
Turkey201147.6
Cyprus201150.0
Greece201152.555.7100.053.152.2100.066.720.00.040.07557.1252068.875
Bulgaria201169.2
Poland
Finland
Romania
Luxembourg
Estonia
Croatia
Latvia
France
Denmark
Ireland
Spain
Italy
Lithuania
Netherlands
Norway
http://www.emcdda.europa.eu/stats13/inffig6b.
For primary sources, study details and data before 2010, see INF-112 and INF-0
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Black squares are samples with national coverage; blue triangles are samples with subnational (including local or regional) coverage. Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of sub-national data.

^Data are from England and Wales for 2011 and from Scotland (prevalence of 34.1) for 2010. 2011 data were collected from April 2011 to March 2012

Sources:

Reitox Network

Country Slovenia Czech Republic Malta Hungary Austria Belgium Sweden United Kingdom Slovakia Germany Portugal Turkey Cyprus Greece Bulgaria
National 10.5 10.7 18.8 19.5 14.8           61.1 47.6 50.0 52.5  
National         32.9           6.1     55.7  
                               
Subnational       22.6 67.9 25.0 27.8 22.2 30.0 26.7       100.0 69.2
 Subnational       10.3 42.6 25.0   34.1   33.3       53.1  
 Subnational       32 40.6                 52.2  
 Subnational       35.9                   100.0  
 Subnational                           66.7  
 Subnational                           20.0  
 Subnational                           0.0  
Subnational                            40.0  
 Subnational                           75  
 Subnational                           57.1  
 Subnational                           25  
 Subnational                           20  
 Subnational                           68.8  
 Subnational                           75  

inffig6b

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 27 November 2013